Gene · 79650
Papers3,560
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,560
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-type-specific proteostasis networks differ across developing human organs. | Philos Trans R Soc Lond B Biol Sci | 2026 | 42817637 | PubTator, text mining | PubMed |
| Divergent somatic mutation patterns among human cerebellar neuron types. | Neuron | 2026 | 42575091 | PubTator, text mining | PubMed |
| Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models. | J Transl Med | 2026 | 42421037 | PubTator, text mining | PubMed |
| Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder. | Neurology | 2026 | 42139635 | PubTator, text mining | PubMed |
| TUT1-catalyzed U6 snRNA 3'-end maturation is essential for RNA splicing and stem cell survival. | EMBO Rep | 2026 | 41957187 | PubTator, text mining | PubMed |
| Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases. | EBioMedicine | 2026 | 41930824 | PubTator, text mining | PubMed |
| Exploring central star variability of planetary nebulae using gaia photometry. | Sci Rep | 2026 | 41876691 | PubTator, text mining | PubMed |
| Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma. | Cell Death Dis | 2026 | 41872155 | PubTator, text mining | PubMed |
| Impact of BCNSP-led parenteral nutrition management on prescribing errors in the neonatal intensive care unit. | J Health Popul Nutr | 2026 | 41857780 | PubTator, text mining | PubMed |
| The α-synuclein proteostasis network and its translational applications in Parkinson's disease. | Proc Natl Acad Sci U S A | 2026 | 41838907 | PubTator, text mining | PubMed |
| Er3+/Yb3+ co-doped ZnS quantum dots: structure, optical properties and up-conversion luminescence. | RSC Adv | 2026 | 41799918 | PubTator, text mining | PubMed |
| Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature review. | Neurooncol Adv | 2026 | 41798680 | PubTator, text mining | PubMed |
| Genetic analysis of children with suspected immunodeficiency: mimickers of inborn errors of immunity. | Eur J Pediatr | 2026 | 41784637 | PubTator, text mining | PubMed |
| Survival impact of pN2a and pN2b nodal status in stage IIB-IIIB non-small cell lung cancer under the 9th TNM classification. | Turk Gogus Kalp Damar Cerrahisi Derg | 2026 | 41757517 | PubTator, text mining | PubMed |
| Research on Protection of a Three-Level Converter-Based Flexible DC Traction Substation System. | Sensors (Basel) | 2026 | 41755291 | PubTator, text mining | PubMed |
| Stability Assessment of Intravenous Iron-Carbohydrate Complexes in Commercial All-in-One Parenteral Nutrition: Potential for Therapeutic Iron Dose Admixing. | Pharmaceutics | 2026 | 41754996 | PubTator, text mining | PubMed |
| Integrating Syndromic Molecular Assays into Routine Diagnostic Microbiology: Benefits and Challenges. | Antibiotics (Basel) | 2026 | 41750480 | PubTator, text mining | PubMed |
| A Numerical Comparison of Petri Net and Ordinary Differential Equation SIR Component Models. | IEEE Access | 2026 | 41743905 | PubTator, text mining | PubMed |
| Clinical Spectrum of Cutaneous, Ocular, and Hair Manifestations in Patients With Inborn Errors of Immunity: Insights From a Single Center in Turkey. | Immun Inflamm Dis | 2026 | 41738375 | PubTator, text mining | PubMed |
| Revisiting the streptococcal M protein: modern perspectives on antibody function, host interactions, and therapeutic targeting. | Front Immunol | 2026 | 41737217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79650/papers